Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-056290
Filing Date
2025-04-21
Accepted
2025-04-21 16:09:52
Documents
2
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1533
2 EX-24 acet-ex24.htm EX-24 11730
  Complete submission text file 0000950170-25-056290.txt   14799
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RESTORBIO, INC. 500 BOYLSTON ST., 12TH FLOOR BOSTON MA 02116
Business Address
Grissinger Michael (Reporting) CIK: 0001757601 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 25853230